Contineum Therapeutics, Inc. (CTNM)
$13.18+3.53%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $493M
- Beta
- 0.75
- P/E (TTM)
- -7.31
- Short % float
- 8.80%
- Days to cover
- 6.9
- SI change
- +4.4%
- 1W
- +1.46%
- 1M
- -12.95%
- vs SPY 1W
- -0.09%
- vs SPY 1M
- -14.71%
Industry peers
FMP comparable companies · ranked by market cap
- RAPPSELLRapport Therapeutics, Inc. Common Stock$1.4BCRISISQ 25$29.85-3.27%
- GHRSSELLGH Research PLC$1.4BCRISISQ 15$20.45-2.90%
- LBRXSELLLB Pharmaceuticals Inc Common Stock$992MCRISISQ 76$34.61+1.32%
- SPTXSELLSeaport Therapeutics, Inc. Common Stock$959MQ -2$17.91-0.11%
- ANROSELLAlto Neuroscience, Inc.$843MCRISISQ 17$24.03+2.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
